DOI: 10.52341/20738080_2025_139_6_36 ISSN: 2073-8080
USE OF INHIBITORS OF TYPE 2 SODIUM-GLUCOSE COTRANSPORTER FOR THE CARDIOPROTECTION IN THE PATIENTS UNDERGOING POTENTIALLY TOXIC ANTI-TUMOR THERAPY. REVIEW OF LITERATURE
Vladimir Salukhov, I. PUZhALOV, A. SANTAKOV, N. VARAVINThe review generalizes the data on the use of inhibitors of type 2 sodium-glucose cotransporter for the cardiac protection in the patients undergoing potentially toxic anti-tumor therapy and systematizes results of new clinical studies.